Építés alatt – nem éles oldal
Belépés

CBD (cannabidiol) & Schizophrenia

Checked 2026. nov. 11. including AI · Schizophrenia

AI-generated image

Written based on 22 research studies on PubMed, searched on 2026. nov. 11..

The claim

Posts online say that CBD (cannabidiol) helps with schizophrenia.

Where research stands

We found 73 published papers on CBD (cannabidiol) and schizophrenia. They were published between 1995 and 2026. 6 of them are studies in people. 6 of them compared people who got it with a group that did not. 30 were studies in animals, and none was only in cells in the lab. 23 papers are reviews that sum up other studies. 6 new studies in people are running or will start soon, say the trial registers.

  • 6In people6 with a comparison group
  • 30In animals
  • 0Only in the lab

What the studies found

We have not summed up these studies in words yet. The most important papers are listed under Sources.

Verdict

CBD (cannabidiol) has been tested in randomised trials in people with schizophrenia.

What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.

Sources

  1. Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Neuropsychopharmacology · Randomised trial
  2. Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia.2024 · BJPsych Open · Randomised trial
  3. Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial.2021 · Front Pharmacol · Randomised trial
  4. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.2018 · Psychopharmacology (Berl) · Randomised trial
  5. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.2018 · Am J Psychiatry · Randomised trial
  6. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.2012 · Transl Psychiatry · Randomised trial
  7. Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis.2026 · Eur Arch Psychiatry Clin Neurosci · Review
  8. Cannabidiol and cognition: a literature review of human randomized controlled trials.2025 · Behav Pharmacol · Review
  9. Investigating Cannabidiol's potential as a supplementary treatment for schizophrenia: A narrative review.2024 · Eur J Pharmacol · Review
  10. Cannabidiol as an antipsychotic drug.2024 · Int Rev Neurobiol · Review
  11. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen.2024 · Front Psychiatry · Review
  12. Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review.2023 · Exp Clin Psychopharmacol · Review
  13. THC and CBD differentially modulated gut microbiota in the Poly I:C rat model of schizophrenia.2026 · Front Pharmacol · In animals
  14. Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility.2026 · Prog Neuropsychopharmacol Biol Psychiatry · In animals
  15. Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine model of schizophrenia: sex-dependent effects on positive-like and cognitive impairments.2026 · Braz J Psychiatry · In animals
  16. Unraveling Cannabidiol's Dual Modulatory Role in Schizophrenia: Network Pharmacology and In Vivo Validation of Neuroinflammatory and Behavioral Modulation.2025 · Mol Neurobiol · In animals
  17. Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.2025 · Schizophr Res · In animals
  18. Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia.2025 · Brain Res · In animals
  19. For those with schizophrenia, does cannabidiol make cannabis use safer?2025 · Neuropsychopharmacology · Other paper
  20. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.2024 · Psychiatry Res · Other paper
  21. Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder.2021 · Front Psychiatry · Other paper
  22. Cannabidiol modulation of hippocampal glutamate in early psychosis.2021 · J Psychopharmacol · Other paper

More checked claims